New Perceptions

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Ketamine-Hypnosis Package (KHP): A Clinical Case Study for the treatment of depression and addiction administering Ketamine with Hypnotherapy. found in the latest issue, with the author Sophie Adler.

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article A Critical Review Investigating whether there are similarities in EEG band waves between Schizophrenic patients and participants given DMT or Ayahuasca Tea found in the latest issue, with the author Medusa Warrior

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article A Ketamine-Induced Episode of Insight: A Case Report found in the latest issue, with the authors Dr. Ben Nissen and Dr. Kelly Bisel.

Follow us:

Saj Razvi obtained his master’s degree in Easter Civilization studies and Counseling Psychology. He currently serves as the Director of Education at the Psychedelic Somatic Institute in Denver, Colorado. His viewpoint article based on his and Steve Elfrink’s white paper The Psychedelic Somatic Interactional Psychotherapy Model: An introduction to a Novel Therapy can be found in the latest issue of the journal.

Psil Silva is the author of The Psychedelic Trip Journal and runs the website Psilocybin Stories, which compiles trip reports from individuals who have used psychedelic mushrooms, as well as provides integration techniques for post-trip experiences.

Dr. Natalie Gukasyan obtained her B.S. from Cornell University and attended Medical School at Tulane University. She completed Psychiatry Residency at John’s Hopkins University School of Medicine. She currently serves a Post-Doctoral Fellow at the Johns Hopkins Center for Psychedelic Consciousness Research and is Assistant Faculty at the Johns Hopkins Bayview Community Psychiatry Program.

Dr. Albert Garcia-Romeu obtained his Ph.D. in Psychology from the Institute of Transpersonal Psychology in 2012 for his research on self-transcendence and meditation. He completed his post-doc in Behavioral Pharmacology. He currently is an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine and is a guest researcher at the National Institute for Drug Abuse Intramural Neuroimaging Research Branch.

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Holotropic Breathwork: A Review found in the latest issue, with the author Dr. John Jacob.

Dr. Thomas Roberts obtained his Master from the University of Connecticut and completed his Ph.D. in Psychology at Stanford University. He is an Emeritus Professor of Psychology at Northern Illinois University and was a founding member of the Multidisciplinary Association for Psychedelic Studies or MAPS.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he reviews the article The Psychiatric Utility of MDMA by Dr. Mark Sundahl found in the latest issue.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Life after attempted death: A case report of symptom mitigation with the use of LSD in methamphetamine use disorder and other psychiatric comorbidities found in the latest issue, with the author Dr. JP Martell.

AJP Article on Ketamine as a treatment for Cocaine Use Disorder:

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss the MDMA, Psilocybin, and Ayahuasca with Special Guest and Psychiatrist Dr. Charles Grob.

Dr. Charles Grob obtained his M.D. from State University of New York and completed residency in Psychiatry. He currently serves as an Investigator for The Lunquist Institute, Professor of Psychiatry and Biobehavioral Sciences and Pediatrics at UCLA SOM, and is the Director of the Child and Adolescent Psychiatry Division at Harbor-UCLA Medical Center. He can also be seen in Netflix’s film Have a Good Trip which is currently available

Referenced Works on Psychedelics:

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Josh Siegel.

Dr. Josh Siegel obtained his BA, MD, and Ph.D. in neuroscience from Washington University in St. Louis, MO. He is currently a PGY2 Psychiatry Resident at Washington University and engaged in research into Treatment-Resistant Depression.

Follow us:

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Scott Aaronson.

Dr. Scott Aaronson obtained his M.D. from Harvard University in 1981. He is currently an Associate Professor at The University of Maryland School of Medicine, a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of The American College of Psychiatrists. He serves on the board of the American Society of Clinical Psychopharmacology and the board of the Clinical TMS Society. He currently is the Director of Clinical Research for The Retreat at Sheppard Pratt.

Referenced Articles on Treatment-Resistant Depression:

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Treatment-Resistant Depression with Special Guest and Psychiatrist Dr. Alan Schatzberg.

Dr. Alan Schatzberg obtained his M.D. from NYU School of Medicine in 1968 and completed his Residency in Psychiatry in 1972 at The Massachusetts Mental Health Center. He has previously served as the 136thPresident of the American Psychiatric Association and was the Chair of Psychiatry Department at Stanford University from 1991-2010. He currently serves as a Professor of Psychiatry and Behavioral Sciences at Stanford University and is the Director of the Stanford Mood Disorders Center

Referenced Articles on Depression and Psychedelics:

Join Editor-in-Chief Dr. Tyler Kjorvestad and Deputy Editor Dr. Joe Pullara of The Journal of Psychedelic Psychiatry as they discuss Dr. Pullara's article Positive Response to Ketamine Administration in Treatment-Resistant Psychosis: A Case Report and Dr. Kjorvestad's accompanying editorial Selective Use of Ketamine in Patients with Psychotic Disorders both of which can be found in the latest issue of the journal online. 

Follow us:

Join the Editors of The Journal of Psychedelic Psychiatry as they discuss Ketamine with Special Guest and Psychiatrist Dr. Dennis Owens. 

Dr. Dennis Owens obtained his undergraduate degree in Chemistry at William Jewell College, attended medical school at The University of Kansas, and completed his Ph. D. in Molecular Biology at Washington University. He has previously served as a Medical Director of Substance Use, Eating Disorder, and Adolescent clinic programs and was the President and Co-Founder of the Midwest Psychiatric Research Group. He is currently an Associate Professor and Director of the Clinical Trials Division and Comprehensive Depression Assessment and Treatment Center at The University of Kansas Health System in Kansas City, KS.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestadof The Journal of Psychedelic Psychiatry as he discusses Psychedelics, Culture, and Politics with Special Guest Nick Gillespie.

Nick Gillespie received his Ph.D. in English Literature from State University of New York at Buffalo in 1996. He is a libertarian journalist for Reason magazine where he has worked since 1993. He has previously served as the publication’s Editor-in-Chief from 2000-2008 and then transitioned to Editor-in-Chief of Reason.com and Reason TV from 2008-2017. He currently serves as Editor-at-Large for Reason. He is the co-author with his Reason colleague Matt Welch of the book The Declaration of Independents: How Libertarian Politics Can Fix What’s Wrong with America. His most recent work can be found at reason.com. He can be heard on The Reason Roundtable podcast every Monday and he also hosts The Reason Interview podcast.

Follow Nick Gillespie

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Psilocybin Assisted Psychotherapy Protocol found in the latest issue, with the author and Editor-at-Large Dr. Gershom Hernandez.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article A Review of the Psychotherapeutic Effects of Ayahuasca from the latest issue, with the author Dr. Adam Bertroche.

Follow us:

Join the Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Integrating Psychedelic Use: A Cautionary Note for Licensed Health Care Providers from the latest issue, with the author Rose Jade. 

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad, Editor-at-Large Dr. Gershom Hernandez, and Associate Editor Dr. Tony Ceman of The Journal of Psychedelic Psychiatry as they review the literature on the use of Psilocybin for the treatment of anxiety and depression in terminally ill cancer patients. 

Articles:

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Join Deputy Editor Dr. Joe Pullara of The Journal of Psychedelic Psychiatry as he discusses the editorial Beyond Vaping: Psilocybin Use for the Treatment of Tobacco Use Disorder from the inaugural issue, with the author and Editor-in-Chief Dr. Tyler Kjorvestad

Follow us:

Join Editor-at-Large Dr. Gershom Hernandez of The Journal of Psychedelic Psychiatry as he discusses the editorial Psychedelic Assisted Psychotherapy for the Treatment of Gender Dysphoria from the inaugural issue, with the author and Editor-in-Chief Dr. Tyler Kjorvestad

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article LSD: A Comprehensive Review from the inaugural issue, with the author and Editor-at-Large Dr. Gershom Hernandez.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Ayahuasca and Treatment of Post-Traumatic Stress Disorder from the inaugural issue, with the author and Deputy Editor Dr. Tony Ceman.

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the article Psilocybin Use in the Future Psychiatric Practice: A Comprehensive Review from the inaugural issue, with the author and Deputy Editor Dr. Tony Ceman

Follow us:

Join Editor-in-Chief Dr. Tyler Kjorvestad of The Journal of Psychedelic Psychiatry as he discusses the feature article from the inaugural issue, Introspective Acceptance of Gender Identity: Case Report Detailing Resolution of Gender Dysphoria After Use of LSD with the author and Deputy Editor Dr. Joe Pullara

Follow us:

Join the Editors of The Journal of Psychedelic Psychiatry for a roundtable discussion regarding whether society is ready for psychedelic based therapies, the legal status of psychedelics, the ongoing research efforts into psychedelic therapies, and the forthcoming inaugural issue of The Journal of Psychedelic Psychiatry.  

Follow us: